Obstructive sleep apnea syndrome is a risk factor for cardiovascular diseases occurrence and progression. The leading pathophysiological mechanism is hyperactivation of the sympathetic autonomic nervous system. Changes in myocardial repolarization processes may serve as an early marker of increased risk for myocardial ischemia in individuals without cardiovascular diseases. Also, it is unclear how the treatment of obstructive sleep apnea syndrome can influence autonomic regulation and myocardial repolarization.
The objective of the study was to evaluate the relationship of autonomic dysfunction and myocardial repolarization abnormalities caused by obstructive sleep apnea syndrome and its changes after the treatment of underlying condition.
Results: 15 patients with obstructive sleep apnea syndrome of mild and moderate degree were enrolled into the study group. The control group was formed from healthy individuals. An increased tonic sympathetic activity was observed in the study group. It was associated with increased values of the T-wave symmetry standard quadratic deviation index. Treatment of obstructive sleep apnea syndrome by otorhinolaryngological procedures (septoplasty, uvulopalatoplasty, removal of nasal polyps, uvulopalatapharyngoplasty) resulted in improvement of tonic autonomic regulation (in terms of sinus rhythm variability) and normalization of myocardial repolarization that were evaluated in 3 months after treatment.
Conclusions. Tonic sympathetic hyperactivation changes the processes of myocardial repolarization in patients with obstructive sleep apnea syndrome. Treatment of obstructive sleep apnea syndrome with otorhinolaryngological procedures improves autonomic regulation and myocardial repolarization processes.
2. Drager LF, Togeiro SM, Polotsky VY, Lorenzi-Filho G. Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome. J Am Coll Cardiol. 2013 Aug 13;62(7):569-76. doi: 10.1016/j.jacc.2013.05.045. Epub 2013 Jun 12.
3. Gonzaga C, Bertolami A, Bertolami M, Amodeo C, Calhoun D. Obstructive sleep apnea, hypertension and cardiovascular diseases. J Hum Hypertens. 2015 Dec;29(12):705-12. doi: 10.1038/jhh.2015.15. Epub 2015 Mar 12.
4. Arnaud C, Bochaton T, Pépin JL, Belaidi E. Obstructive sleep apnoea and cardiovascular consequences: Pathophysiological mechanisms. Arch Cardiovasc Dis. 2020 Mar 26. pii: S1875-2136(20)30041-3. doi: 10.1016/j.acvd.2020.01.003.
5. Katerenchuk OI. Vehetatyvna dysfunktsiia pry syndromi sonnykh apnoe ta sposoby yii medykamentoznoi korektsii. Universytetska klinika. Multymorbidnist i komorbidnist u poli profilnii likarni : materialy nauk.-prakt. konf. z mizhnar. uchastiu, m. Kharkiv, 14 bereznia 2019 r. Kharkiv, 2019, рр. 46–48.
6. Faynzilberg LS, Minina EN. Otsenka funktsionalnogo sostoyaniya serdechno-sosudistoy sistemy po velichine razbrosa fazovykh trayektoriy odnokanalnoy EKG. Kibernetika i vychislitelnaya tekhnika. 2014; 175: 5-19.
7. Faynzilberg LS, Minina EN. Issledovaniye diagnosticheskoy tsennosti ugla oriyentatsii fazovogo portreta odnokanalnoy EKG kak indikatora funktsionalnogo sostoyaniya miokardа. Klinicheskaya informatika i telemeditsina. 2013; 9(10): 33-42.
8. Faynzilberg LS. Osnovy fazagrafii. Kiyev: Osvita Ukrainy, 2017. 264 p.
9. Bozbas SS, Eroglu S, Ozyurek BA, Eyuboglu FO. Coronary flow reserve is impaired in patients with obstructive sleep apnea. Ann Thorac Med. 2017 Oct-Dec;12(4):272-277. doi: 10.4103/atm.ATM_195_16.
10. Zhang RH, Zhao W, Shu LP, Wang N, Cai YH, Yang JK, Zhou JB, Qi L. Obstructive sleep apnea is associated with coronary microvascular dysfunction: A systematic review from a clinical perspective. J. Sleep Res. 2020 Apr 15:e13046. doi: 10.1111/jsr.13046.
This work is licensed under a Creative Commons Attribution 4.0 International License.